SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001610618-16-000011
Filing Date
2016-11-10
Accepted
2016-11-10 16:05:30
Documents
48
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cdtx10-q2016x09x30.htm 10-Q 778249
2 EXHIBIT 10.2 exhibit102.htm EX-10.2 100172
3 EXHIBIT 31.1 exhibit311-10q.htm EX-31.1 9115
4 EXHIBIT 31.2 exhibit312-10q.htm EX-31.2 9082
5 EXHIBIT 32.1 exhibit321-10q.htm EX-32.1 6582
6 EXHIBIT 32.2 exhibit322-10q.htm EX-32.2 6588
  Complete submission text file 0001610618-16-000011.txt   3453187

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT cdxt-20160930.xml EX-101.INS 555977
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cdxt-20160930.xsd EX-101.SCH 25867
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cdxt-20160930_cal.xml EX-101.CAL 43633
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cdxt-20160930_def.xml EX-101.DEF 117455
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cdxt-20160930_lab.xml EX-101.LAB 399885
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cdxt-20160930_pre.xml EX-101.PRE 212125
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36912 | Film No.: 161988031
SIC: 2836 Biological Products, (No Diagnostic Substances)